Christine Fox - Nov 14, 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Head of U.S. Commercial
Signature
/s/ Dov Bergwerk as attorney-in-fact for Christine Fox
Stock symbol
TEVA
Transactions as of
Nov 14, 2025
Transactions value $
-$753,321
Form type
4
Date filed
11/18/2025, 04:01 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fox Christine EVP, Head of U.S. Commercial C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL /s/ Dov Bergwerk as attorney-in-fact for Christine Fox 2025-11-18 0001998173

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Sale -$753K -30K -51.38% $25.11 28.4K Nov 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.